Skip to main content

The department’s research programs are located on the UCI main campus and UCI Medical Center. They are supported by funding from the National Institutes of Health (NIH) and other extramural sources. In 2022, the department became a top 30 pathology department for NIH funding. The department hosts individual and center-based research programs with translational and clinical goals in laboratory diagnostics, neurotherapeutics and cell-based therapies.

  • Cancer
  • Inflammation
  • Immunology
  • Microbial pathogenesis
  • Cutting-edge pathology imaging (e.g., cleared tissues)
  • Glycobiology
  • Point-of-care test innovation
  • Stem cell biology and regenerative medicine
  • Neuroscience (developmental)
  • Neuroscience (aging and neurodegeneration)
  • Computational pathology (digital pathology and multimodal AI)
  • Precision “omics,” including spatial omics

Experimental Tissue Resource Shared Facility

In collaboration with the NCI-designated Chao Family Comprehensive Cancer Center, the UCI Department of Pathology & Laboratory Medicine hosts the Experimental Tissue Resource (ETR) Shared Facility.

Doctor holding test tube of patient blood sample